reports
- GlobalData Healthcare Department
Aquinox Pharmaceuticals Inc (AQXP) - Financial Analysis Review
Aquinox Pharmaceuticals Inc (AQXP) - Financial Analysis Review Summary Aquinox Pharmaceuticals Inc (Aquinox) is a clinical-stage pharmaceutical company which develops targeted therapeutics in the areas of inflammation and immuno-oncology. The company's lead product candidate AQX-1125, is a SHIP1 activator which is a natural modulator of the PI3K pathway to reduce inflammatory diseases. GlobalData's Aquinox Pharmaceuticals Inc (AQXP) - Financial Analysis Review provides a comprehensive insight...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.